Cellebrite DI vs PagerDuty
PagerDuty reported revenue of $492 million in fiscal 2026, about the same as Cellebrite DI's $476 million in fiscal 2025. Cellebrite DI's revenue grew 18.6% in its latest year, and PagerDuty's grew 5.4%. Cellebrite DI had an operating margin of 14.0%, against 1.2% at PagerDuty. Free cash flow was $160 million at Cellebrite DI and $112 million at PagerDuty. Their fiscal years end in different months (December 31 and January 31), so the periods don't line up exactly.
Side by side
| Cellebrite DI | PagerDuty | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, Jan 31, 2026 |
| Revenue | $476M | $492M |
| Revenue growth | 18.6% | 5.4% |
| Revenue growth a year, last 5 years | 19.5% | 18.2% |
| Gross margin | 84.2% | 85.0% |
| Operating margin | 14.0% | 1.2% |
| Net margin | 16.5% | 35.2% |
| Free cash flow | $160M | $112M |
| Free cash flow margin | 33.7% | 22.7% |
| Return on capital | — | 4.7% |
| Net debt to EBITDA | — | −2.6x |
| Dividends and buybacks | $0M | $135M |
| Change in diluted share count | 19.3% | 1.1% |
| Last close | $11.32 | $15.78 |
| P/E at the last close | — | 7.8× |
| Insider trades, last 12 months | sold $5.5 million | sold $12.1 million |
| Piotroski F-score | — | 7 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Cellebrite DIPagerDuty
Operating margin
Percent of revenue
Cellebrite DIPagerDuty
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Cellebrite DIPagerDuty
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cellebrite DI and PagerDuty pages.